Uterine thermal balloon therapy for the treatment of menorrhagia: the first 300 patients from a multi-centre study. International Collaborative Uterine Thermal Balloon Working Group.

Objective: To evaluate the safety and efficacy of thermal balloon therapy for menorrhagia.

Design: Prospective, observational study.

Setting: Fifteen centres in Canada and Europe.

Clinical trial of the uterine thermal balloon for treatment of menorrhagia.

Study Objectives: To evaluate the safety and efficacy of thermal balloon endometrial ablation in women with menorrhagia, and to identify factors influencing outcome.

Design: Prospective, observational study (Canadian Task Force classification II-2).

Setting: Three Canadian university-affiliated teaching hospitals.

Uterine Balloon Therapy for the Treatment of Menorrhagia.

From June 1994 to December 1995, 116 women (mean age 39 yrs, range 27-50 yrs) who met inclusion and exclusion criteria underwent endometrial ablation with a thermal balloon system. Forty-one (35%) were treated under general and 71 (61%) under neuroleptic anesthesia. Four (3%) treatments were performed under paracervical block only.

Endometrial ablation with a thermal balloon for the treatment of menorrhagia.

Study Objective: To evaluate the safety and clinical efficacy of a uterine thermal balloon endometrial ablation system for the treatment of menorrhagia.

Design: Prospective pilot study.

Setting: University-affiliated teaching hospital.